Skip to main content
Log in

Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the accuracy of diffusion-weighted magnetic resonance imaging (DW-MRI) in differentiating HCC from benign cirrhotic lesions compared with conventional dynamic contrast-enhanced MRI. Fifty-five patients with cirrhosis underwent conventional and DW-MRI at 1.5 Tesla. Signal intensity ratios (SIratio) of solid liver lesions to adjacent hepatic parenchyma were measured for b0, b100, b600 and b1000, and the apparent diffusion coefficients (ADC) were calculated. In 27 patients, imaging results were compared to histopathology, and in 28 patients, to imaging follow-up. Based on predetermined thresholds, sensitivity and specificity of DW-MRI and conventional MRI were compared. SIratio was significantly different between malignant and benign lesions at all b-values (P < 0.0001). No significant difference in ADC was seen (P = 0.47). For detection of malignant lesions, DW-MRI with b600-SIratio yielded a sensitivity of 95.2% compared to 80.6% for conventional MRI (P = 0.023) and a specificity of 82.7% compared to 65.4% (P = 0.064). The improved accuracy was most beneficial for differentiating malignant lesions smaller than 2 cm. DW-MRI with b600-SIratio improved the detection of small HCC and the differentiation of pseudotumoral lesions compared with conventional MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Yeh CN, Chen MF, Lee WC, Jeng LB (2002) Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 81:195–202

    Article  PubMed  Google Scholar 

  2. Adler M, De Pauw F, Vereerstraeten P et al (2008) Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl 14:526–533

    Article  PubMed  Google Scholar 

  3. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL (2000) Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31:330–335

    Article  PubMed  CAS  Google Scholar 

  4. Taouli B, Losada M, Holland A, Krinsky G (2004) Magnetic resonance imaging of hepatocellular carcinoma. Gastroenterology 127:144–152

    Article  Google Scholar 

  5. Willat JM, Hussain HK, Adusumilli S, Marrero JA (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330

    Article  Google Scholar 

  6. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505

    PubMed  Google Scholar 

  7. Bammer R (2003) Basic principles of diffusion-weighted imaging. Eur J Radiol 45:169–184

    Article  PubMed  Google Scholar 

  8. Melhem ER, Itoh R, Jones L, Barker PB (2000) Diffusion tensor MR imaging of the brain: effect of diffusion weighting on trace and anisotropy measurements. AJNR Am J Neuroradiol 21:1813–1820

    PubMed  CAS  Google Scholar 

  9. Low RN, Gurney J (2007) Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 25:848–858

    Article  PubMed  Google Scholar 

  10. Ross BD, Moffat BA, Lawrence TS et al (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2:581–587

    PubMed  CAS  Google Scholar 

  11. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patient. Radiology 226:71–78

    Article  PubMed  Google Scholar 

  12. Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812–822

    Article  PubMed  Google Scholar 

  13. Low RN (2007) Abdominal MRI advances in the detection of liver tumours and characterisation. Lancet Oncol 8:525–535

    Article  PubMed  Google Scholar 

  14. Xu H, Li X, Xie JX, Yang ZH, Wang B (2007) Diffusion-weighted magnetic resonance imaging of focal hepatic nodules in an experimental hepatocellular carcinoma rat model. Acad Radiol 14:279–286

    Article  PubMed  Google Scholar 

  15. Kelekis NL, Semelka RC, Worawattanakul S et al (1998) Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 170:1005–1013

    PubMed  CAS  Google Scholar 

  16. Libbrecht L, Bielen D, Verslype C et al (2002) Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8:749–761

    Article  PubMed  Google Scholar 

  17. Couinaud C (1957) Le foie. Etudes anatomiques et chirurgicales. Masson, Paris

    Google Scholar 

  18. International Working Party (1995) Terminology of nodular hepatocellular lesions of the liver: recommendations of the World Congress of Gastroenterology Working Group. Hepatology 22:983–993

    Google Scholar 

  19. Kojiro M, Roskams T (2005) Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis 25:133–142

    Article  PubMed  Google Scholar 

  20. Van Lom KJ, Brown JJ, Perman WH, Sandstrom JC, Lee JK (1991) Liver imaging at 1.5 Tesla: pulse sequence optimization based on improved measurement of tissue relaxation times. Magn Reson Imaging 9:165–171

    Article  PubMed  Google Scholar 

  21. Mion F, Grozel L, Boillot O, Paliard P, Berger F (1996) Adult cirrhotic liver explants: precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 111:1587–1592

    Article  PubMed  CAS  Google Scholar 

  22. Pandharipande PV, Krinsky GA, Rusinek H, Lee VS (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661–673

    Article  PubMed  Google Scholar 

  23. Roncalli M, Roz E, Coggi G et al (1990) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178

    Article  Google Scholar 

  24. Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635

    Article  PubMed  Google Scholar 

  25. Hollingsworth KG, Lomas DJ (2006) Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 19:231–235

    Article  PubMed  CAS  Google Scholar 

  26. Thoeny HC, De Keyzer F, Vandecaveye V et al (2005) Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 237:492–499

    Article  PubMed  Google Scholar 

  27. Roth Y, Tichler T, Kostenich G et al (2004) High-b-value diffusion-weighted MR imaging for pre-treatment prediction and early monitoring of tumor response to therapy in mice. Radiology 232:685–692

    Article  PubMed  Google Scholar 

  28. Bruegel M, Holzapfel K, Gaa J et al (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477–485

    Article  PubMed  Google Scholar 

  29. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71–78

    Article  PubMed  Google Scholar 

  30. Sun XJ, Quan XY, Huang FH, Xu YK (2005) Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 11:6535–6537

    PubMed  Google Scholar 

  31. Takayama T, Makuuchi M, Kojiro M et al (2008) Early hepatocellular carcinoma: pathology, imaging and therapy. Ann Surg Oncol 15:972–978

    Article  PubMed  Google Scholar 

  32. Earls JP, Theise ND, Weinreb JC et al (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201:207–214

    PubMed  CAS  Google Scholar 

  33. Kim T, Murakami T, Oi H et al (1995) Detection of hypervascular hepatocellular carcinoma by dynamic MRI and dynamic spiral CT. J Comput Assist Tomogr 19:948–954

    Article  PubMed  CAS  Google Scholar 

  34. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023–1039

    PubMed  Google Scholar 

  35. van den Bos IC, Hussain SM, Dwarkasing RS et al (2007) MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 26:1548–1555

    Article  PubMed  Google Scholar 

  36. Earls JP, Theise ND, Weinreb JC et al (1996) Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201:207–214

    PubMed  CAS  Google Scholar 

  37. Coenegrachts K, Delanote J, Ter Beek L et al (2007) Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 80:524–531

    Article  PubMed  CAS  Google Scholar 

  38. Maluf DG, Stravitz RT, Williams B et al (2007) Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience. Transplant Proc 39:153–159

    Article  PubMed  CAS  Google Scholar 

  39. Shimizu A, Ito K, Koike S, Fujita T, Shimizu K, Matsunaga N (2003) Cirrhosis or chronic hepatitis: evaluation of small (≤2-cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 226:550–555

    Article  PubMed  Google Scholar 

  40. Tsushima Y, Takano A, Taketomi-Takahashi A, Endo K (2007) Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images. Acad Radiol 14:643–650

    Article  PubMed  Google Scholar 

  41. Krinsky G (2004) Imaging of dysplastic nodules and small hepatocellular carcinomas: experience with explanted livers. Intervirology 47:191–198

    Article  PubMed  Google Scholar 

  42. Caudana R, Morana G, Pirovano GP et al (1996) Focal malignant hepatic lesions: MR enhanced with gadolinium benzylproprionictetra-acetate (BOPTA). Preliminary results of phase II clinical application. Radiology 199:513–520

    PubMed  CAS  Google Scholar 

  43. Manfredi R, Maresca G, Baron RL et al (1999) Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA). J Magn Reson Imaging 9:704–710

    Article  PubMed  CAS  Google Scholar 

  44. Choi SH, Lee JM, Yu NC et al (2008) Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI. Am J Roentgenol 191:529–536

    Article  Google Scholar 

Download references

Acknowledgements

This work was partly financially supported by the research grant ‘Prof. Em. A. L. Baert, Siemens Medical Solutions’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent Vandecaveye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vandecaveye, V., De Keyzer, F., Verslype, C. et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 19, 2456–2466 (2009). https://doi.org/10.1007/s00330-009-1431-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-009-1431-5

Keywords

Navigation